-69%

est. 2Y upside i

Series A

Rank

#1424

Sector

Food Technology

Est. Liquidity

~4Y

Data Quality

Data: Medium

Leaftfoods presents a high-risk, moderate-upside equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (20%)+350%

Leaftfoods successfully scales its proprietary Rubisco extraction, securing major B2B contracts in the plant-based protein and pet food markets, and expanding its D2C Leaft Blade brand in the US. Strong market adoption of its functional and allergen-free Rubisco protein, coupled with successful regulatory approvals in key markets like Japan, drives revenue to over $50M by 2028, justifying a $340M valuation (4.5x current) as a leader in a high-growth niche.

Base (40%)+75%

Leaftfoods continues to grow its B2B ingredient sales and sees moderate success with Leaft Blade, but faces intense competition from larger incumbents and other Rubisco startups. Revenue reaches $20M-$25M by 2028, leading to a Series B round at a modest uplift, valuing the company at $132.5M (1.75x current). Common shareholders see some return, but dilution from future rounds remains a factor.

Bear (40%)-80%

Leaftfoods struggles to achieve cost-effective commercial scale or faces significant delays in regulatory approvals. Dominant incumbents or well-funded competitors like Plantible gain a stronger foothold in the Rubisco market, commoditizing the technology or outcompeting on price/scale. Growth stalls, leading to a down round or acquisition at a valuation of $15.1M (0.2x current), resulting in minimal to no return for common shareholders due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $15M in liquidation preferences ahead of common shareholders. In an exit at or below the current $75.7M valuation, common stock holders may receive little to nothing after preferred shares are paid out.

Dilution Risk

high

As a Series A company with $15M raised, Leaftfoods will likely undergo further funding rounds (Series B, C, etc.), leading to significant dilution for existing common shareholders.

Secondary Liquidity

none

There is no active secondary market for Leaftfoods' shares at this early stage, limiting immediate liquidity options for employees.

Questions to Ask at the Interview

Strategic questions based on Leaftfoods's data — designed to show you've done your homework.

  • 1

    “Given the intense competition from large incumbents like Impossible Foods and ingredient giants like Ingredion, how does Leaftfoods plan to differentiate its Rubisco protein beyond its functional properties to secure significant market share?”

  • 2

    “With a current team of 14 employees and a Series A valuation, what are the key milestones and financial targets Leaftfoods aims to achieve in the next 18-24 months to prepare for a successful Series B round and mitigate dilution risk for early employees?”

  • 3

    “Considering the $15M in liquidation preferences ahead of common stock, what is the company's strategy to ensure meaningful returns for common shareholders in various exit scenarios, and what is the estimated timeline for a potential liquidity event?”

Community

Valuation Sentiment

Our model estimates -69% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.